LGND · Transaction May 29, 2026 · Filed Jun 8, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · LGND
-0.80% · -$2.43 · Vol 393.8K
Market closed · last close 4:00 PM ET · price as of 16:00:11 ET
Ligand Pharmaceuticals Inc
Pharmaceuticals
$300.14
Veridion Score
BETAHIGH CONF · 6/6 factorsThu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET · LGND
MethodologyLGND
Ligand Pharmaceuticals Inc
Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
71/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is LGND moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Ligand Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONSListed since
1994
Employees
47
Country
US
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$306.08
Day high
$317.49
Day low
$297.31
Previous close
$302.57
52W high
$322.61
-6.97% from high
52W low
$146.32
87% of range
Market cap
$6.1B
P/E
39.90×
EPS
$3.04
Beta
0.82
Shares out
20M
Volume
393.8K
0.99× rel vol
Avg volume
397.7K
VWAP
$306.65
Price history computed in-house
1W
+4.38%
1M
-4.68%
3M
+35.56%
1Y
+105.13%
YTD
+58.75%
SMA 50 $282.27 · above
SMA 200 $222.58 · above
52W position 87%
LGND overview
Related filings and maps
Public disclosures
Congress activity in LGND
Official filing ↗
LGND · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
LGND · Transaction Jan 15, 2026 · Filed Feb 13, 2026 · $1,001 to $15,000
LGND · Transaction Jan 5, 2026 · Filed Feb 13, 2026 · $1,001 to $15,000
LGND Common Stock · Transaction Oct 22, 2020 · Filed Dec 3, 2020 · Amount pending receipt enrichment
Federal contracts
LGND contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LGND in this window.
Lobbying spend
LGND lobbying filings, year to date.
Registered lobbying filings matched to Ligand Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LGND in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for LGND.
Options
Sovereign unlock shows live options positioning for LGND.